Henry Leher

722 total citations
23 papers, 588 citations indexed

About

Henry Leher is a scholar working on Endocrinology, Ophthalmology and Rheumatology. According to data from OpenAlex, Henry Leher has authored 23 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, 10 papers in Ophthalmology and 10 papers in Rheumatology. Recurrent topics in Henry Leher's work include Legionella and Acanthamoeba research (11 papers), Systemic Lupus Erythematosus Research (9 papers) and Ocular Infections and Treatments (8 papers). Henry Leher is often cited by papers focused on Legionella and Acanthamoeba research (11 papers), Systemic Lupus Erythematosus Research (9 papers) and Ocular Infections and Treatments (8 papers). Henry Leher collaborates with scholars based in United States, Netherlands and Germany. Henry Leher's co-authors include Hassan Alizadeh, Jérry Y. Niederkorn, James P. McCulley, Robert Silvany, Jing Huang, Kevin Howard, Martine J. Jager, MJ JAGER, Sharath S. Hegde and Daniel B. Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Infection and Immunity.

In The Last Decade

Henry Leher

23 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Leher United States 11 407 309 220 137 112 23 588
Steffi Hälbich Germany 5 7 0.0× 90 0.3× 60 0.3× 81 0.6× 373 3.3× 6 504
R L Cranfill United States 8 17 0.0× 85 0.3× 9 0.0× 88 0.6× 314 2.8× 8 481
Arif A. Khan United States 16 8 0.0× 131 0.4× 45 0.2× 44 0.3× 332 3.0× 24 588
Linling Shen United States 11 5 0.0× 87 0.3× 32 0.1× 123 0.9× 429 3.8× 15 605
Kathrin Steinwede Germany 9 22 0.1× 117 0.4× 5 0.0× 19 0.1× 259 2.3× 12 456
S Schondelmaier Germany 8 14 0.0× 82 0.3× 8 0.0× 23 0.2× 561 5.0× 9 678
Sakari Jokiranta Finland 9 4 0.0× 55 0.2× 29 0.1× 75 0.5× 238 2.1× 18 459
E. G. Rondanelli Italy 11 49 0.1× 87 0.3× 4 0.0× 14 0.1× 26 0.2× 51 319
Manabu Ogawa Japan 8 5 0.0× 33 0.1× 379 1.7× 36 0.3× 23 0.2× 11 466
Manuel Coutaz Switzerland 6 7 0.0× 83 0.3× 6 0.0× 84 0.6× 240 2.1× 7 374

Countries citing papers authored by Henry Leher

Since Specialization
Citations

This map shows the geographic impact of Henry Leher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Leher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Leher more than expected).

Fields of papers citing papers by Henry Leher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Leher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Leher. The network helps show where Henry Leher may publish in the future.

Co-authorship network of co-authors of Henry Leher

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Leher. A scholar is included among the top collaborators of Henry Leher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Leher. Henry Leher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menn‐Josephy, Hanni, et al.. (2023). Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria. Clinical Journal of the American Society of Nephrology. 19(3). 309–318. 6 indexed citations
2.
Parikh, Samir V., et al.. (2023). Repeat Kidney Biopsies from the AURORA 2 Study of Voclosporin in Active Lupus Nephritis. Journal of the American Society of Nephrology. 34(11S). 9–9. 1 indexed citations
3.
Saxena, Amit, et al.. (2022). 1202 Voclosporin for Lupus Nephritis: Results of the Two-year AURORA 2 Continuation Study. SHILAP Revista de lepidopterología. A85–A86. 3 indexed citations
4.
Caster, Dawn J., et al.. (2022). Long-Term Use of Voclosporin in Patients With Class V Lupus Nephritis: Results From the AURORA 2 Continuation Study. Journal of the American Society of Nephrology. 33(11S). 498–498. 2 indexed citations
5.
Anders, Hans‐Joachim, et al.. (2022). 1110 Voclosporin is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations. SHILAP Revista de lepidopterología. A75.2–A76. 1 indexed citations
6.
Askanase, Anca, et al.. (2022). FC056: Early Reductions in Proteinuria with Voclosporin Treatment Across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV AND AURORA 1 Trials. Nephrology Dialysis Transplantation. 37(Supplement_3). 1 indexed citations
7.
Parikh, Samir V., Cristina Arriens, Lucy S. Hodge, Christopher M. Mela, & Henry Leher. (2022). Voclosporin for Lupus Nephritis: Assessment of Long-Term Safety and Efficacy Including Renal Outcome Over 3 Years of Treatment in the Phase 3 AURORA 1 and AURORA 2 Studies. Journal of the American Society of Nephrology. 33(11S). 184–184. 1 indexed citations
8.
Fleischmann, Roy, et al.. (2021). Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors. Lara D. Veeken. 60(11). 4991–5001. 17 indexed citations
9.
Charles‐Schoeman, Christina, Gregory St John, Henry Leher, et al.. (2019). E064 The relationship between lipid profile changes and inflammation across the Phase 3 sarilumab rheumatoid arthritis (RA) development programme. Lara D. Veeken. 58(Supplement_3). 3 indexed citations
10.
Niederkorn, Jérry Y., Hassan Alizadeh, Henry Leher, et al.. (2002). Role of Tear Anti-Acanthamoeba IgA in Acanthamoeba Keratitis. Advances in experimental medicine and biology. 506(Pt B). 845–850. 5 indexed citations
11.
Leher, Henry, et al.. (2001). Exacerbation ofAcanthamoebaKeratitis in Animals Treated with Anti-Macrophage Inflammatory Protein 2 or Antineutrophil Antibodies. Infection and Immunity. 69(5). 2988–2995. 54 indexed citations
12.
Niederkorn, Jérry Y., Hassan Alizadeh, Henry Leher, et al.. (2000). ROLE OF TEAR ANTI-ACANTHAMOEBA IgA IN ACANTHAMOEBA KERATITIS.. Cornea. 19(Supplement 2). S110–S110. 1 indexed citations
13.
Clark, Abbot F., Jessamee Mellon, Xiaoyan Li, et al.. (1999). Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate.. PubMed. 40(9). 2158–62. 51 indexed citations
14.
Niederkorn, Jérry Y., Hassan Alizadeh, Henry Leher, & James P. McCulley. (1999). The immunobiology of Acanthamoeba keratitis. Springer Seminars in Immunopathology. 21(2). 147–160. 28 indexed citations
15.
Niederkorn, Jérry Y., Hassan Alizadeh, Henry Leher, & James P. McCulley. (1999). The immunobiology ofAcanthamoeba keratitis. Springer Seminars in Immunopathology. 21(2). 147–160. 8 indexed citations
16.
Niederkorn, Jérry Y., Hassan Alizadeh, Henry Leher, & James P. McCulley. (1999). The pathogenesis of keratitis. Microbes and Infection. 1(6). 437–443. 139 indexed citations
17.
Leher, Henry, et al.. (1999). Monoclonal IgA Antibodies Protect Against Acanthamoeba Keratitis. Experimental Eye Research. 69(1). 75–84. 38 indexed citations
18.
Leher, Henry, et al.. (1998). Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection.. PubMed. 39(12). 2337–43. 33 indexed citations
19.
Leher, Henry, et al.. (1998). Role of mucosal IgA in the resistance to Acanthamoeba keratitis.. PubMed. 39(13). 2666–73. 45 indexed citations
20.
Leher, Henry, et al.. (1997). Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. Ocular Immunology and Inflammation. 5(4). 235–244. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steffi Hälbich Breakdown of academic impact, for papers by R L Cranfill Breakdown of academic impact, for papers by Arif A. Khan Breakdown of academic impact, for papers by Linling Shen Breakdown of academic impact, for papers by Kathrin Steinwede Breakdown of academic impact, for papers by S Schondelmaier Breakdown of academic impact, for papers by Sakari Jokiranta Breakdown of academic impact, for papers by E. G. Rondanelli Breakdown of academic impact, for papers by Manabu Ogawa Breakdown of academic impact, for papers by Manuel Coutaz
Rankless by CCL
2026